Agence nationale de recherches sur le sida et les hépatites virales

Agence nationale de recherches sur le sida et les hépatites virales is a research organisation in Paris, France that has taken part in 2 EU-funded projects since 2010, receiving €128k in EU funding.

EU funding received€128k
EU projects2
As coordinator0
Running now0
First EU project2010
Latest project2010
CountryFrance
EU registration (PIC)994632084
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Agence nationale de recherches sur le sida et les hépatites virales's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€128k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • HIVERAPartner

    Harmonizing, Integrating and Vitalizing European Research on hiv/Aids

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €124ktheir share
  • IDEAPartner

    Dissecting the Immunological Interplay between Poverty Related Diseases and Helminth Infections: An African-European Research Initiative

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €4ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • immunology
  • malaria
  • vaccines

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime